Sponsor

University of Maryland Greenebaum Cancer Center

Clinical research sponsor

Published trials3

Recruiting shown1

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesNCT05627960 · collaborator · 2022-02-14

RECRUITING

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and BiomarkersNCT01118975 · collaborator · 2010-03-01

TERMINATED

Efficacy and Safety of 500mg of FulvestrantNCT00585507 · collaborator · 2004-04-01

ACTIVE_NOT_RECRUITING

Sponsor roles

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.